Search results for "Breast-conserving surgery"

showing 8 items of 8 documents

Prospective randomized comparison of conventional instruments and the Harmonic Focus(®) device in breast-conserving therapy for primary breast cancer.

2011

Abstract Background In recent years, surgeons have utilized Harmonic instruments to perform breast cancer resection. Retrospective and prospective studies have demonstrated that the use of this surgical device for mastectomy and axillary dissection can reduce perioperative blood loss, seroma formation, and duration and total amount of drainage. No study has analyzed the feasibility of Harmonic instruments in breast-conserving surgery. We conducted a prospective, randomized clinical trial comparing Harmonic instrument and conventional surgery in the performance of breast-conserving surgery and axillary procedures to determine differences in surgical procedures, postoperative outcome, and com…

Adultmedicine.medical_specialtymedicine.medical_treatmentUltrasonic TherapyBreast NeoplasmsMastectomy SegmentalRisk AssessmentStatistics Nonparametriclaw.inventionBreast cancerPostoperative ComplicationsRandomized controlled triallawGermanymedicineBreast-conserving surgeryHumansNeoplasm InvasivenessProspective StudiesProspective cohort studyAgedNeoplasm StagingPostoperative CareAcademic Medical CentersChi-Square Distributionbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseSurgical InstrumentsSurvival AnalysisSurgeryLogistic ModelsSeromaTreatment OutcomeOncologySeromaMultivariate AnalysisSurgeryFemaleNeoplasm Recurrence LocalComplicationbusinessChi-squared distributionMastectomyFollow-Up StudiesEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Przegląd metod śródoperacyjnej oceny marginesów w chirurgicznym leczeniu oszczędzającym gruczoł piersiowy

2021

Breast conserving therapy is the primary treatment modality in early-stage breast cancer patients. Despite the development of methods for the intraoperative assessment of tumor margins, 20–30% of patients still require re-resection due to postoperative tumor infiltration at the surgery margins. In recent years, many methods have been developed to reduce the number of re-resections due to margin infiltration. Here we review the current methods together with several more techniques under investigation.

Cancer Researchmedicine.medical_specialtySurgical marginbusiness.industrymedicine.medical_treatmentmedicine.diseaseRe resectionBreast cancerOncologyMargin (machine learning)medicineBreast-conserving surgeryPrimary treatmentRadiologybusinessNowotwory. Journal of Oncology
researchProduct

Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment

2012

Abstract Background A large proportion of women with breast cancer (BC) are elderly. However, there is a lack of information regarding BC prognostic factors and care in this population. The aims of this study were to assess the prognostic factors of relative survival (RS) among women with BC aged ≥ 75 years old and to identify the predictive factors of treatments administered to this population. Methods A population-based study was performed using data from the Cote d’Or breast and gynaecological cancer registry. Women aged 75 years and older with primary invasive BC and resident in Cote d’Or at the time of diagnosis made between January 1998 and December 2008 were retrospectively selected.…

Cancer Researchmedicine.medical_treatmentComorbidityBreast cancerBreast-conserving surgeryRegistriesMastectomyAged 80 and overeducation.field_of_studyPredictors of treatmentRelative survivalPrognosislcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCombined Modality TherapyTreatment OutcomeOncologyPopulation SurveillanceHypertensionFemaleFranceMastectomyResearch Articlemedicine.medical_specialtyPopulationBreast NeoplasmsPrognostic factorsRelative survivallcsh:RC254-282Breast cancerDrug TherapyInternal medicineDiabetes MellitusmedicineAdjuvant therapyGeneticsHumansObesityElderly womeneducationSurvival analysisAgedNeoplasm StagingRetrospective StudiesGynecologyRadiotherapybusiness.industrymedicine.diseaseSurvival AnalysisLogistic ModelsMultivariate AnalysisHormone therapybusinessFollow-Up StudiesBMC Cancer
researchProduct

A new case of radiation-induced breast angiosarcoma

2019

Highlights • A biopsy of any suspicious breast skin lesion after radiotherapy is recommended. • Patients with clinical anomalies post-breast cancer surgery and RT need attention. • The Angiosarcoma was cured due to surgery and high-dose neoadjuvant chemotherapy. • A correct 6 month follow-up is needed: check-ups, chest X-rays and ultrasound. • The survival of the patient suggests possible ways to manage this rare tumour type.

Chemotherapymedicine.medical_specialtyRadiotherapymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentCancermedicine.diseaseArticleRadiation therapy03 medical and health sciences0302 clinical medicineBreast cancerBreast-conserving surgery030220 oncology & carcinogenesisBiopsyAngiosarcomamedicineBreast-conserving surgery030211 gastroenterology & hepatologySurgeryAngiosarcomaRadiologybusinessMastectomyInternational Journal of Surgery Case Reports
researchProduct

In breast cancer, are treatments and survival the same whatever a patient's age? A population-based study over the period 1998-2009

2014

Aim The present study aimed to describe treatments, relative survival and prognostic factors in breast cancer patients according to age. Methods All women with primary invasive breast cancer, diagnosed from 1998 to 2009 in the department of Cote d'Or, were retrospectively selected. Variations in treatments administered according to age ( 74 years) and period were assessed using Cochran–Armitage trend tests and χ2-tests, respectively. Prognostic factors according to age were estimated using a generalized linear model with a Poisson error structure. Results Overall, 4305 women were included. The oldest women (aged >74 years) were more likely than the youngest women to have comorbidities, adva…

Gynecologymedicine.medical_specialtyRelative survivalbusiness.industryTumor biologymedicine.medical_treatmentmedicine.diseasePopulation based studyBreast cancerInternal medicineBreast-conserving surgeryAdjuvant therapyMedicineHormone therapybusinessHormoneGeriatrics & Gerontology International
researchProduct

Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study

2013

This population-based study aimed to describe the effects of neoadjuvant chemotherapy (NC) on survival in breast cancer (BC) patients in daily practice. BC patients treated with NC followed by surgery and radiotherapy, were retrospectively selected from 1982 to 2005 using the Cote d’Or BC registry. These patients were matched for the baseline AJCC (American Joint Committee on Cancer) stage, age at diagnosis, date of diagnosis and oestrogens receptors status to those who had undergone surgery followed by adjuvant chemotherapy and radiotherapy. The prognostic effect of NC on survival in BC patients was assessed with relative survival (RS) analyses. From 1982 to 2005, 210 patients with BC diag…

Oncologymedicine.medical_specialtyeducation.field_of_studyRelative survivalbusiness.industrymedicine.medical_treatmentPopulationCancermedicine.diseaseCancer registryRadiation therapyBreast cancerOncologyInternal medicinemedicineBreast-conserving surgeryStage (cooking)educationbusinessEuropean Journal of Cancer Care
researchProduct

Male breast cancer: Modified radical mastectomy or breast conservation surgery? A case report and review of the literature

2016

INTRODUCTION: Male breast cancer (MBC) is a rare disease that accounts for <1% of breast cancer cases. The most common treatment is modified radical mastectomy (MRM). Recently, breast conservative surgery (BCS) is getting popular for MBC treatment. We report a case and reviewed the literature to investigate whether emerging BCS can be considered as an alternative of a more radical surgery. PRESENTATION OF CASE: A 46 y.o. patient, presented with a painless left breast lump over a period of six months. The patient underwent a quadrantectomy at another institution. Pathology revealed an intraductal carcinoma in close proximity to the margins of excision. Adjuvant hormonal therapy was proposed …

medicine.medical_specialtyBreast; Breast conserving surgery; Case report; Chest wall reconstruction; Male breast cancer; Mastectomy; Surgerymedicine.medical_treatmentSettore MED/19 - Chirurgia PlasticaModified Radical Mastectomy03 medical and health sciences0302 clinical medicineBreast cancerBreast conserving surgeryCase reportmedicineBreast-conserving surgeryBreastRadical surgeryskin and connective tissue diseasesMastectomyBreast conservationbusiness.industryGeneral surgerymedicine.diseaseSurgeryMale breast cancer030220 oncology & carcinogenesisMale breast cancerSurgerybusinessChest wall reconstruction030217 neurology & neurosurgeryMastectomyRare disease
researchProduct

Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients

2005

Abstract Purpose The aim of this study is to describe the University of Florence experience in evaluating clinical, pathologic and treatment factors as they are related to the outcome and loco-regional recurrence in patients with tubular breast carcinoma. Material and methods Three hundred and seven patients (median age 56.4 years, range 26–91 years) with histological verified tubular carcinoma of the breast were consecutively treated at University of Florence from 1976 to 2001. All patients were followed for a median of 8.4 years (range 3 months to 20 years). Thirty-seven women underwent mastectomy and 270 underwent breast conserving surgery. Positive axillary nodes were found in 15% of pa…

medicine.medical_treatmentDiseaseSegmentalMastectomy SegmentalBreast cancerDuctalBreast-conserving surgery80 and overBreastAdjuvantMastectomyAged 80 and overCarcinoma Ductal BreastTubular carcinomaGeneral MedicineMiddle AgedCombined Modality TherapyTreatment OutcomeBreast cancer; Radiotherapy; Tubular carcinoma; Adenocarcinoma; Adult; Aged; Aged 80 and over; Antineoplastic Agents Hormonal; Axilla; Breast Neoplasms; Carcinoma Ductal Breast; Chemotherapy Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Mastectomy; Mastectomy Segmental; Middle Aged; Neoplasm Recurrence Local; Proportional Hazards Models; Radiotherapy Adjuvant; Survival Analysis; Tamoxifen; Treatment Outcome; Oncology; SurgeryLocalOncologyChemotherapy AdjuvantLymphatic MetastasisFemaleMastectomymedicine.drugAdultmedicine.medical_specialtyAntineoplastic Agents HormonalAntineoplastic AgentsBreast NeoplasmsAdenocarcinomaBreast cancermedicineChemotherapyHumansAgedProportional Hazards ModelsChemotherapyRadiotherapyHormonalbusiness.industryCarcinomamedicine.diseaseSurvival AnalysisSurgeryRadiation therapyTamoxifenNeoplasm RecurrenceAxillaRadiotherapy AdjuvantSurgeryTubular carcinomaNeoplasm Recurrence LocalbusinessTamoxifen
researchProduct